Abbott Laboratories is a Dividend King with 53 years of dividend growth. Leerink Partners initiated coverage with a target price of $143, indicating a slight upside. The company recently gained approval for a rapid blood test in Canada.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing